dostarlimumab作为一种有前景的子宫内膜癌免疫疗法-文献综述

Kamila Derlatka, Justyna Tasior, Marika Kulczycka, Wioletta Pasieczna, Monika Prendecka-Wróbel
{"title":"dostarlimumab作为一种有前景的子宫内膜癌免疫疗法-文献综述","authors":"Kamila Derlatka, Justyna Tasior, Marika Kulczycka, Wioletta Pasieczna, Monika Prendecka-Wróbel","doi":"10.26444/jpccr/172403","DOIUrl":null,"url":null,"abstract":"1. Alexa M, Hasenburg A, Battista MJ. The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions. Cancers (Basel). 2021;13(6):1478. doi:10.3390/cancers13061478. CrossRef Google Scholar","PeriodicalId":16886,"journal":{"name":"Journal of Pre-Clinical and Clinical Research","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dostarlimab as a promising immunotherapy for endometrial cancer treatment – literature review\",\"authors\":\"Kamila Derlatka, Justyna Tasior, Marika Kulczycka, Wioletta Pasieczna, Monika Prendecka-Wróbel\",\"doi\":\"10.26444/jpccr/172403\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"1. Alexa M, Hasenburg A, Battista MJ. The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions. Cancers (Basel). 2021;13(6):1478. doi:10.3390/cancers13061478. CrossRef Google Scholar\",\"PeriodicalId\":16886,\"journal\":{\"name\":\"Journal of Pre-Clinical and Clinical Research\",\"volume\":\"23 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pre-Clinical and Clinical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26444/jpccr/172403\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pre-Clinical and Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26444/jpccr/172403","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

1. Alexa M, Hasenburg A, Battista MJ。子宫内膜癌的TCGA分子分类及其对辅助治疗决策的可能影响。癌症(巴塞尔)。2021; 13(6): 1478。doi: 10.3390 / cancers13061478。交叉参考谷歌学术
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Dostarlimab as a promising immunotherapy for endometrial cancer treatment – literature review
1. Alexa M, Hasenburg A, Battista MJ. The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions. Cancers (Basel). 2021;13(6):1478. doi:10.3390/cancers13061478. CrossRef Google Scholar
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
25
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信